1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P1098A
    Ac2-26 TFA Inhibitor 99.67%
    Ac2-26 TFA,是 annexin 1 的 N 末端肽,具有抗炎活性。Ac2-26 通过伴侣介导的自噬 (CMA) 诱导溶酶体中 IKKβ 蛋白的减少。Ac2-26 可改善肺缺血再灌注损伤。Ac2-26 还可抑制哮喘大鼠模型的气道炎症和高反应性。
    Ac2-26 TFA
  • HY-N2515
    Ginsenoside Rk1

    人参皂苷

    Inhibitor 99.90%
    Ginsenoside Rk1 人参皂苷 Rk1 是人参的高温加工提取物。 Ginsenoside Rk1 具有抗炎作用,抑制 Jak2/Stat3 信号通路和 NF-κB 的激活。 Ginsenoside Rk1 具有抗肿瘤作用,抗血小板聚集活性,抗炎作用,抗胰岛素抵抗,肾保护作用,抗菌作用,认知功能增强,脂质积聚减少和预防骨质疏松症。 Ginsenoside Rk1 通过触发细胞内活性氧 (ROS) 生成和阻断 PI3K/Akt 途径诱导细胞凋亡。
    Ginsenoside Rk1
  • HY-N0375
    18α-Glycyrrhetinic acid

    18-α-甘草次酸

    Inhibitor 99.87%
    18α-Glycyrrhetinic acid,一种饮食衍生的化合物,是 NF-kB 的抑制剂和蛋白酶体 (proteasome) 的激活剂,在多细胞生物中起到促进长寿和抗聚集因子的作用。18α-Glycyrrhetinic acid 诱导细胞凋亡。
    18α-Glycyrrhetinic acid
  • HY-N0633
    Muscone

    麝香酮

    Inhibitor ≥98.0%
    Muscone 是中药麝香的主要活性单体。Muscone 抑制 NF-κBNLRP3 炎性小体的活化。Muscone 显着降低炎性细胞因子 (IL-1βTNF-αIL-6) 水平,并最终改善心脏功能和存活率。
    Muscone
  • HY-N2149
    Tomatidine

    番茄碱

    Inhibitor ≥98.0%
    Tomatidine 通过阻断 NF-κBJNK 信号发挥抗炎作用。Tomatidine 激活哺乳动物细胞或秀丽隐杆线虫中的自噬 (autophagy)。
    Tomatidine
  • HY-N0708
    Vanillic acid

    香草酸

    Inhibitor 99.75%
    Vanillic acid 是一种在食用植物和水果中发现的调味剂,在当归根部也可以发现。Vanillic acid 抑制 NF-κB 活化。具有抗炎,抗菌等活性。
    Vanillic acid
  • HY-P9958
    Denosumab

    地舒单抗

    Inhibitor 99.10%
    Denosumab 是一种靶向 RANKL 蛋白的人单克隆抗体。Denosumab 结合 receptor activator of nuclear factor kappa-B ligand (RANKL) 并阻止其与 RANK 受体结合 (对人 RANKL 的 KD 为 0.003 nM)。Denosumab 促进增殖和精子发生。Denosumab 通过抑制 NF-κB 途径防止骨吸收。Denosumab 可用于骨相关研究。
    Denosumab
  • HY-N0031
    Plantamajoside

    车前子甙

    Inhibitor 99.80%
    Plantamajoside 是一种具有口服活性的苯丙烷类糖苷。Plantamajoside 可从车前 Plantago asiatica L. 中分离出来。Plantamajoside 失活 NF-κB, PI3K/akt, 诱导凋亡 (Apoptosis), 改善自噬 (Autophagy)。Plantamajoside 调节 MAPK, integrin-linked kinase/c-Src。Plantamajoside 抑制多种癌症,改善肺、肾损伤。Plantamajoside 具有神经保护和抗炎作用。
    Plantamajoside
  • HY-N0441
    Neferine

    甲基莲心碱

    Inhibitor 99.92%
    Neferine 是一种双苄基异喹啉类生物碱。Neferine 强效抑制 NF-κB 激活。
    Neferine
  • HY-N0108
    Physcion

    大黄素甲醚

    Inhibitor 99.00%
    Physcion (Parietin) 是从中药大黄中得到的蒽醌类物质,是具有口服有效性和血脑屏障透过性的 6-磷酸葡萄糖酸脱氢酶 (6-phosphogluconate dehydrogenase) 抑制剂,IC50Kd 值分别为 38.5 μM 和 26.0 μM。同时,Physcion 也是 TLR4/NF-kB 信号通路抑制剂,具有抗炎、抗菌、抗癌作用,可诱导癌细胞凋亡 (Apoptosis) 和自噬 (Autophagy)。
    Physcion
  • HY-17473
    Embelin

    恩贝酸

    Inhibitor 99.01%
    Embelin (Embelic acid) 是一种有效的、非肽类的细胞渗透性 XIAP 抑制剂 (IC50=4.1 μM),在高水平 XIAP 的前列腺癌细胞中抑制细胞生长,诱导凋亡 (apoptosis),并激活 caspase-9。Embelin 阻断 NF-kappaB 信号通路,从而抑制 NF-kappaB 调节的抗凋亡和转移基因产物。Embelin 诱导口腔鳞癌细胞自噬和凋亡。
    Embelin
  • HY-N0652
    2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside

    2,3,5,4-四羟基二苯乙烯葡萄糖苷

    Inhibitor 99.91%
    2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside 是从蓼科植物物种的根里分离出来的,能够抑制5-HETE、HHT 和 thromboxane B2 的形成。2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside 具有降血压、抗衰老、抗炎、降血脂、心脏保护和神经保护作用。
    2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside
  • HY-N0722
    Neochlorogenic acid

    新绿原酸

    Inhibitor 99.77%
    Neochlorogenic acid 是在干果和其他植物中发现的一种天然多酚化合物。Neochlorogenic acid 抑制 TNF-αIL-1β 产生。 Neochlorogenic acid 抑制 iNOSCOX-2 蛋白表达。Neochlorogenic acid 还抑制磷酸化的 NF-κB p65p38 MAPK 活化。
    Neochlorogenic acid
  • HY-Y1362
    Ethyl pyruvate

    丙酮酸乙酯

    Inhibitor 99.87%
    Ethyl pyruvate 是内源性代谢物丙酮酸的简单衍生物。Ethyl pyruvate 是一种 HMGB1 释放抑制剂。Ethyl pyruvate 可通过自噬 (autophagy) 诱导细胞凋亡 (apoptosis)。Ethyl pyruvate 具有抗炎、抗氧化和抗肿瘤活性。Ethyl pyruvate 可用于神经退行性疾病如阿尔茨海默病和帕金森病的研究。
    Ethyl pyruvate
  • HY-100507
    Avadomide Inhibitor 99.56%
    Avadomide 是口服有效的 cereblon 调节剂。Avadomide 可以调节 cereblon E3 连接酶活性,抑制 NF-κB 通路,在 G1 期阻滞细胞周期,从而诱导癌细胞 PDAC 的细胞凋亡 (apoptosis)。Avadomide 具有抗肿瘤和免疫调节活性。
    Avadomide
  • HY-109017
    Vamorolone

    地塞米松EP杂质E

    Inhibitor 99.48%
    Vamorolone (VBP15) 是首创的,具有口服活性的解离性类固醇 (dissociative steroidal) 抗炎剂和膜稳定剂。Vamorolone 改善肌营养不良,无副作用。Vamorolone 抑制 (NF-κB) 抑制作用,并降低了激素的影响。
    Vamorolone
  • HY-N0044
    Ginsenoside Re

    人参皂苷 Re

    Inhibitor 99.22%
    Ginsenoside Re (Ginsenoside B2) 是一种 Panax notoginseng 提取物。Ginsenoside Re 可降低 β-淀粉样蛋白 ()。Ginsenoside Re 还通过抑制 JNKNF-κB 发挥抗炎作用。
    Ginsenoside Re
  • HY-N6949
    Juglone

    胡桃醌

    Inhibitor 99.77%
    Juglone (5-Hydroxy-1,4-naphthalenedione) 是可从胡桃 Juglans regia 中提取的一种黄色染料。Juglone 通过线粒体途径诱导细胞凋亡。Juglone 具有抗菌、抗肿瘤活性。
    Juglone
  • HY-126307
    Urolithin B

    尿石素B

    Inhibitor 99.85%
    Urolithin B 是 Ellagitannins 的肠道微生物代谢产物之一,具有抗炎和抗氧化作用。Urolithin B 通过降低 IκBα 的磷酸化和降解来抑制 NF-κB 活性。Urolithin B 抑制 JNKERKAkt 的磷酸化,增强 AMPK 的磷酸化。Urolithin B 也是骨骼肌质量的调节因子。
    Urolithin B
  • HY-15122A
    Sinomenine hydrochloride

    盐酸青藤碱

    Inhibitor 99.89%
    Sinomenine hydrochloride (Cucoline hydrochloride) 是来自 Sinomenium acutum 的一种生物碱,是 NF-κB 活化的阻断剂。Sinomenine 也是 μ 阿片受体 (μ-opioid receptor) 激活剂。
    Sinomenine hydrochloride
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.